Weishampel, Zachary A.
Nagahawatte, Ajith
Wijayaratne, Gaya
Wickramasinghe, Subodha S.
Nicholson, Bradly
Anderson, Jack
Vanderburg, Sky
Fonseka, Chathuranga Lakmal
Premamali, Madureka
Rolfe, Robert J.
Dilshan, U.H.B.Y.
Kurukulasooriya, Ruvini
Piyasiri, D.L.B.
Østbye, Truls
Woods, Christopher W.
Abusalem, Lana
Obale, Armstrong
Tillekeratne, L. Gayani
Bodinayake, Champica K.
Funding for this research was provided by:
Duke Hubert-Yeargan Center for Global Health
National Institutes of Health Fogarty Training Grant (D43 TW009337)
National Institutes of Allergy and Infectious Diseases (K23AI125677)
Article History
Received: 22 April 2025
Accepted: 20 August 2025
First Online: 29 September 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: Research was conducted in accordance with the Declaration of Helsinki. Ethical approval for this study was obtained from both the Ethical Review Committee of the Faculty of Medicine, University of Ruhuna, Sri Lanka and from the Duke University Institutional Review Board, USA (Pro00092502). For patients who were 18 years or older, written informed consent was obtained. For patients younger than 18 years of age, written informed consent was acquired from the parent or legal guardian. Written assent was also obtained from patients 12–17 years of age.